chr7-88075657-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001324418.2(ADAM22):​c.355C>T​(p.His119Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00264 in 1,613,714 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0054 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 68 hom. )

Consequence

ADAM22
NM_001324418.2 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.818

Publications

9 publications found
Variant links:
Genes affected
ADAM22 (HGNC:201): (ADAM metallopeptidase domain 22) This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. Unlike other members of the ADAM protein family, the protein encoded by this gene lacks metalloprotease activity since it has no zinc-binding motif. This gene is highly expressed in the brain and may function as an integrin ligand in the brain. In mice, it has been shown to be essential for correct myelination in the peripheral nervous system. Alternative splicing results in several transcript variants.[provided by RefSeq, Dec 2010]
ADAM22 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 61
    Inheritance: Unknown, AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0037610233).
BP6
Variant 7-88075657-C-T is Benign according to our data. Variant chr7-88075657-C-T is described in ClinVar as Benign. ClinVar VariationId is 717926.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00537 (818/152214) while in subpopulation EAS AF = 0.0374 (194/5184). AF 95% confidence interval is 0.0331. There are 11 homozygotes in GnomAd4. There are 414 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 Unknown,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAM22NM_001324418.2 linkc.355C>T p.His119Tyr missense_variant Exon 4 of 32 ENST00000413139.2 NP_001311347.1 H7C3I4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAM22ENST00000413139.2 linkc.355C>T p.His119Tyr missense_variant Exon 4 of 32 5 NM_001324418.2 ENSP00000412085.2 H7C3I4

Frequencies

GnomAD3 genomes
AF:
0.00535
AC:
814
AN:
152096
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0100
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0373
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00554
AC:
1382
AN:
249350
AF XY:
0.00446
show subpopulations
Gnomad AFR exome
AF:
0.0105
Gnomad AMR exome
AF:
0.0142
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0377
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.000159
Gnomad OTH exome
AF:
0.00331
GnomAD4 exome
AF:
0.00235
AC:
3438
AN:
1461500
Hom.:
68
Cov.:
30
AF XY:
0.00220
AC XY:
1602
AN XY:
727050
show subpopulations
African (AFR)
AF:
0.0113
AC:
377
AN:
33466
American (AMR)
AF:
0.0143
AC:
638
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26132
East Asian (EAS)
AF:
0.0506
AC:
2005
AN:
39650
South Asian (SAS)
AF:
0.000348
AC:
30
AN:
86232
European-Finnish (FIN)
AF:
0.000449
AC:
24
AN:
53412
Middle Eastern (MID)
AF:
0.00426
AC:
24
AN:
5636
European-Non Finnish (NFE)
AF:
0.000115
AC:
128
AN:
1111900
Other (OTH)
AF:
0.00350
AC:
211
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
161
322
483
644
805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00537
AC:
818
AN:
152214
Hom.:
11
Cov.:
32
AF XY:
0.00556
AC XY:
414
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0100
AC:
416
AN:
41526
American (AMR)
AF:
0.0109
AC:
166
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.0374
AC:
194
AN:
5184
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4832
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10596
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000338
AC:
23
AN:
68002
Other (OTH)
AF:
0.00663
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
41
82
122
163
204
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00228
Hom.:
4
Bravo
AF:
0.00637
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00888
AC:
33
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00531
AC:
641
Asia WGS
AF:
0.0120
AC:
43
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ADAM22: BP4, BS1, BS2 -

ADAM22-related disorder Benign:1
Apr 29, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
15
DANN
Uncertain
0.98
DEOGEN2
Benign
0.024
.;T;T;.;T;.;T
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.19
FATHMM_MKL
Benign
0.65
D
LIST_S2
Benign
0.81
T;T;T;T;T;T;T
MetaRNN
Benign
0.0038
T;T;T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.5
L;.;.;L;L;L;.
PhyloP100
0.82
PrimateAI
Benign
0.48
T
PROVEAN
Uncertain
-3.9
D;D;D;D;D;D;D
REVEL
Benign
0.034
Sift
Benign
0.073
T;T;T;D;T;T;D
Sift4G
Uncertain
0.043
D;T;T;D;D;D;D
Polyphen
0.073
B;B;.;.;B;B;.
Vest4
0.22
MVP
0.40
MPC
0.63
ClinPred
0.045
T
GERP RS
2.3
Varity_R
0.22
gMVP
0.64
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4728730; hg19: chr7-87704972; COSMIC: COSV55980842; API